Global HIV Therapeutics Market Insights, Forecast to 2028

Q: Who are the key players in the hiv therapeutics market?

Some of the key players are Boehringer Ingelheim International GmbH, Merck, ViiV Healthcare, AbbVie, F Hoffmann La Roche Ltd, Teva Pharmaceutical Industries Ltd, Bristol–Myers Squibb, Gilead Sciences, Johnson & Johnson, Cipla Ltd, Others.

Code: QYRE-Auto-22W5974

Report

January 2022

Pages:107

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

Merck

ViiV Healthcare

AbbVie

F Hoffmann La Roche Ltd

Teva Pharmaceutical Industries Ltd

HIV Therapeutics Market

The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.

The global HIV Therapeutics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

HIV spreads through fluidic exchange with some infected person such as blood transfer or sharing needles with someone who is HIV infected. In addition, HIV can spread from infected mother to child during pregnancy. Some of the symptoms of HIV infection are slight fever, fatigue, swollen glands, headaches and muscle aches.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HIV Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HIV Therapeutics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HIV Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HIV Therapeutics market.

HIV Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global HIV Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type

Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists

By Application

Hospitals
Clinics
Labs

By Company

Merck & Co.
Boehringer Ingelheim International GmbH
ViiV Healthcare
AbbVie
Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
Cipla Limited

By Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

Merck

ViiV Healthcare

AbbVie

F Hoffmann La Roche Ltd

Teva Pharmaceutical Industries Ltd

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global HIV Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

1.2.4 Entry and Fusion Inhibitors

1.2.5 Protease Inhibitors (PIs)

1.2.6 Integrase Inhibitors

1.2.7 Coreceptor Antagonists

1.3 Market by Application

1.3.1 Global HIV Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Labs

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global HIV Therapeutics Market Perspective (2017-2028)

2.2 HIV Therapeutics Growth Trends by Region

2.2.1 HIV Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 HIV Therapeutics Historic Market Size by Region (2017-2022)

2.2.3 HIV Therapeutics Forecasted Market Size by Region (2023-2028)

2.3 HIV Therapeutics Market Dynamics

2.3.1 HIV Therapeutics Industry Trends

2.3.2 HIV Therapeutics Market Drivers

2.3.3 HIV Therapeutics Market Challenges

2.3.4 HIV Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top HIV Therapeutics Players by Revenue

3.1.1 Global Top HIV Therapeutics Players by Revenue (2017-2022)

3.1.2 Global HIV Therapeutics Revenue Market Share by Players (2017-2022)

3.2 Global HIV Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by HIV Therapeutics Revenue

3.4 Global HIV Therapeutics Market Concentration Ratio

3.4.1 Global HIV Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by HIV Therapeutics Revenue in 2021

3.5 HIV Therapeutics Key Players Head office and Area Served

3.6 Key Players HIV Therapeutics Product Solution and Service

3.7 Date of Enter into HIV Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 HIV Therapeutics Breakdown Data by Type

4.1 Global HIV Therapeutics Historic Market Size by Type (2017-2022)

4.2 Global HIV Therapeutics Forecasted Market Size by Type (2023-2028)

5 HIV Therapeutics Breakdown Data by Application

5.1 Global HIV Therapeutics Historic Market Size by Application (2017-2022)

5.2 Global HIV Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America HIV Therapeutics Market Size (2017-2028)

6.2 North America HIV Therapeutics Market Size by Type

6.2.1 North America HIV Therapeutics Market Size by Type (2017-2022)

6.2.2 North America HIV Therapeutics Market Size by Type (2023-2028)

6.2.3 North America HIV Therapeutics Market Share by Type (2017-2028)

6.3 North America HIV Therapeutics Market Size by Application

6.3.1 North America HIV Therapeutics Market Size by Application (2017-2022)

6.3.2 North America HIV Therapeutics Market Size by Application (2023-2028)

6.3.3 North America HIV Therapeutics Market Share by Application (2017-2028)

6.4 North America HIV Therapeutics Market Size by Country

6.4.1 North America HIV Therapeutics Market Size by Country (2017-2022)

6.4.2 North America HIV Therapeutics Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe HIV Therapeutics Market Size (2017-2028)

7.2 Europe HIV Therapeutics Market Size by Type

7.2.1 Europe HIV Therapeutics Market Size by Type (2017-2022)

7.2.2 Europe HIV Therapeutics Market Size by Type (2023-2028)

7.2.3 Europe HIV Therapeutics Market Share by Type (2017-2028)

7.3 Europe HIV Therapeutics Market Size by Application

7.3.1 Europe HIV Therapeutics Market Size by Application (2017-2022)

7.3.2 Europe HIV Therapeutics Market Size by Application (2023-2028)

7.3.3 Europe HIV Therapeutics Market Share by Application (2017-2028)

7.4 Europe HIV Therapeutics Market Size by Country

7.4.1 Europe HIV Therapeutics Market Size by Country (2017-2022)

7.4.2 Europe HIV Therapeutics Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific HIV Therapeutics Market Size (2017-2028)

8.2 Asia-Pacific HIV Therapeutics Market Size by Type

8.2.1 Asia-Pacific HIV Therapeutics Market Size by Type (2017-2022)

8.2.2 Asia-Pacific HIV Therapeutics Market Size by Type (2023-2028)

8.2.3 Asia-Pacific HIV Therapeutics Market Share by Type (2017-2028)

8.3 Asia-Pacific HIV Therapeutics Market Size by Application

8.3.1 Asia-Pacific HIV Therapeutics Market Size by Application (2017-2022)

8.3.2 Asia-Pacific HIV Therapeutics Market Size by Application (2023-2028)

8.3.3 Asia-Pacific HIV Therapeutics Market Share by Application (2017-2028)

8.4 Asia-Pacific HIV Therapeutics Market Size by Region

8.4.1 Asia-Pacific HIV Therapeutics Market Size by Region (2017-2022)

8.4.2 Asia-Pacific HIV Therapeutics Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America HIV Therapeutics Market Size (2017-2028)

9.2 Latin America HIV Therapeutics Market Size by Type

9.2.1 Latin America HIV Therapeutics Market Size by Type (2017-2022)

9.2.2 Latin America HIV Therapeutics Market Size by Type (2023-2028)

9.2.3 Latin America HIV Therapeutics Market Share by Type (2017-2028)

9.3 Latin America HIV Therapeutics Market Size by Application

9.3.1 Latin America HIV Therapeutics Market Size by Application (2017-2022)

9.3.2 Latin America HIV Therapeutics Market Size by Application (2023-2028)

9.3.3 Latin America HIV Therapeutics Market Share by Application (2017-2028)

9.4 Latin America HIV Therapeutics Market Size by Country

9.4.1 Latin America HIV Therapeutics Market Size by Country (2017-2022)

9.4.2 Latin America HIV Therapeutics Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa HIV Therapeutics Market Size (2017-2028)

10.2 Middle East & Africa HIV Therapeutics Market Size by Type

10.2.1 Middle East & Africa HIV Therapeutics Market Size by Type (2017-2022)

10.2.2 Middle East & Africa HIV Therapeutics Market Size by Type (2023-2028)

10.2.3 Middle East & Africa HIV Therapeutics Market Share by Type (2017-2028)

10.3 Middle East & Africa HIV Therapeutics Market Size by Application

10.3.1 Middle East & Africa HIV Therapeutics Market Size by Application (2017-2022)

10.3.2 Middle East & Africa HIV Therapeutics Market Size by Application (2023-2028)

10.3.3 Middle East & Africa HIV Therapeutics Market Share by Application (2017-2028)

10.4 Middle East & Africa HIV Therapeutics Market Size by Country

10.4.1 Middle East & Africa HIV Therapeutics Market Size by Country (2017-2022)

10.4.2 Middle East & Africa HIV Therapeutics Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Boehringer Ingelheim International GmbH

11.1.1 Boehringer Ingelheim International GmbH Company Details

11.1.2 Boehringer Ingelheim International GmbH Business Overview

11.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Introduction

11.1.4 Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2017-2022)

11.1.5 Boehringer Ingelheim International GmbH Recent Developments

11.2 Merck & Co.

11.2.1 Merck & Co. Company Details

11.2.2 Merck & Co. Business Overview

11.2.3 Merck & Co. HIV Therapeutics Introduction

11.2.4 Merck & Co. Revenue in HIV Therapeutics Business (2017-2022)

11.2.5 Merck & Co. Recent Developments

11.3 ViiV Healthcare

11.3.1 ViiV Healthcare Company Details

11.3.2 ViiV Healthcare Business Overview

11.3.3 ViiV Healthcare HIV Therapeutics Introduction

11.3.4 ViiV Healthcare Revenue in HIV Therapeutics Business (2017-2022)

11.3.5 ViiV Healthcare Recent Developments

11.4 AbbVie

11.4.1 AbbVie Company Details

11.4.2 AbbVie Business Overview

11.4.3 AbbVie HIV Therapeutics Introduction

11.4.4 AbbVie Revenue in HIV Therapeutics Business (2017-2022)

11.4.5 AbbVie Recent Developments

11.5 F. Hoffmann-La Roche Ltd.

11.5.1 F. Hoffmann-La Roche Ltd. Company Details

11.5.2 F. Hoffmann-La Roche Ltd. Business Overview

11.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Introduction

11.5.4 F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2017-2022)

11.5.5 F. Hoffmann-La Roche Ltd. Recent Developments

11.6 Teva Pharmaceutical Industries Ltd.

11.6.1 Teva Pharmaceutical Industries Ltd. Company Details

11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Introduction

11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2017-2022)

11.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments

11.7 Bristol-Myers Squibb

11.7.1 Bristol-Myers Squibb Company Details

11.7.2 Bristol-Myers Squibb Business Overview

11.7.3 Bristol-Myers Squibb HIV Therapeutics Introduction

11.7.4 Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2017-2022)

11.7.5 Bristol-Myers Squibb Recent Developments

11.8 Gilead Sciences

11.8.1 Gilead Sciences Company Details

11.8.2 Gilead Sciences Business Overview

11.8.3 Gilead Sciences HIV Therapeutics Introduction

11.8.4 Gilead Sciences Revenue in HIV Therapeutics Business (2017-2022)

11.8.5 Gilead Sciences Recent Developments

11.9 Johnson & Johnson

11.9.1 Johnson & Johnson Company Details

11.9.2 Johnson & Johnson Business Overview

11.9.3 Johnson & Johnson HIV Therapeutics Introduction

11.9.4 Johnson & Johnson Revenue in HIV Therapeutics Business (2017-2022)

11.9.5 Johnson & Johnson Recent Developments

11.10 Cipla Limited

11.10.1 Cipla Limited Company Details

11.10.2 Cipla Limited Business Overview

11.10.3 Cipla Limited HIV Therapeutics Introduction

11.10.4 Cipla Limited Revenue in HIV Therapeutics Business (2017-2022)

11.10.5 Cipla Limited Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim International GmbH

Merck

ViiV Healthcare

AbbVie

F Hoffmann La Roche Ltd

Teva Pharmaceutical Industries Ltd

List of Tables

Table 1. Global HIV Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)

Table 3. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Table 4. Key Players of Entry and Fusion Inhibitors

Table 5. Key Players of Protease Inhibitors (PIs)

Table 6. Key Players of Integrase Inhibitors

Table 7. Key Players of Coreceptor Antagonists

Table 8. Global HIV Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 9. Global HIV Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 10. Global HIV Therapeutics Market Size by Region (2017-2022) & (US$ Million)

Table 11. Global HIV Therapeutics Market Share by Region (2017-2022)

Table 12. Global HIV Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 13. Global HIV Therapeutics Market Share by Region (2023-2028)

Table 14. HIV Therapeutics Market Trends

Table 15. HIV Therapeutics Market Drivers

Table 16. HIV Therapeutics Market Challenges

Table 17. HIV Therapeutics Market Restraints

Table 18. Global HIV Therapeutics Revenue by Players (2017-2022) & (US$ Million)

Table 19. Global HIV Therapeutics Revenue Share by Players (2017-2022)

Table 20. Global Top HIV Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2021)

Table 21. Ranking of Global Top HIV Therapeutics Companies by Revenue (US$ Million) in 2021

Table 22. Global 5 Largest Players Market Share by HIV Therapeutics Revenue (CR5 and HHI) & (2017-2022)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players HIV Therapeutics Product Solution and Service

Table 25. Date of Enter into HIV Therapeutics Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global HIV Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 28. Global HIV Therapeutics Revenue Market Share by Type (2017-2022)

Table 29. Global HIV Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 30. Global HIV Therapeutics Revenue Market Share by Type (2023-2028)

Table 31. Global HIV Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 32. Global HIV Therapeutics Revenue Share by Application (2017-2022)

Table 33. Global HIV Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 34. Global HIV Therapeutics Revenue Share by Application (2023-2028)

Table 35. North America HIV Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 36. North America HIV Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 37. North America HIV Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 38. North America HIV Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 39. North America HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 40. North America HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 41. Europe HIV Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 42. Europe HIV Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 43. Europe HIV Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 44. Europe HIV Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 45. Europe HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 46. Europe HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 47. Asia Pacific HIV Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 48. Asia Pacific HIV Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 49. Asia Pacific HIV Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 50. Asia Pacific HIV Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 51. Asia Pacific HIV Therapeutics Market Size by Region (2017-2022) & (US$ Million)

Table 52. Asia Pacific HIV Therapeutics Market Size by Region (2023-2028) & (US$ Million)

Table 53. Latin America HIV Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 54. Latin America HIV Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 55. Latin America HIV Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 56. Latin America HIV Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 57. Latin America HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 58. Latin America HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 59. Middle East and Africa HIV Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 60. Middle East and Africa HIV Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 61. Middle East and Africa HIV Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 62. Middle East and Africa HIV Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 63. Middle East and Africa HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 64. Middle East and Africa HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 65. Boehringer Ingelheim International GmbH Company Details

Table 66. Boehringer Ingelheim International GmbH Business Overview

Table 67. Boehringer Ingelheim International GmbH HIV Therapeutics Product

Table 68. Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)

Table 69. Boehringer Ingelheim International GmbH Recent Developments

Table 70. Merck & Co. Company Details

Table 71. Merck & Co. Business Overview

Table 72. Merck & Co. HIV Therapeutics Product

Table 73. Merck & Co. Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)

Table 74. Merck & Co. Recent Developments

Table 75. ViiV Healthcare Company Details

Table 76. ViiV Healthcare Business Overview

Table 77. ViiV Healthcare HIV Therapeutics Product

Table 78. ViiV Healthcare Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)

Table 79. ViiV Healthcare Recent Developments

Table 80. AbbVie Company Details

Table 81. AbbVie Business Overview

Table 82. AbbVie HIV Therapeutics Product

Table 83. AbbVie Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)

Table 84. AbbVie Recent Developments

Table 85. F. Hoffmann-La Roche Ltd. Company Details

Table 86. F. Hoffmann-La Roche Ltd. Business Overview

Table 87. F. Hoffmann-La Roche Ltd. HIV Therapeutics Product

Table 88. F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)

Table 89. F. Hoffmann-La Roche Ltd. Recent Developments

Table 90. Teva Pharmaceutical Industries Ltd. Company Details

Table 91. Teva Pharmaceutical Industries Ltd. Business Overview

Table 92. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Product

Table 93. Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)

Table 94. Teva Pharmaceutical Industries Ltd. Recent Developments

Table 95. Bristol-Myers Squibb Company Details

Table 96. Bristol-Myers Squibb Business Overview

Table 97. Bristol-Myers Squibb HIV Therapeutics Product

Table 98. Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)

Table 99. Bristol-Myers Squibb Recent Developments

Table 100. Gilead Sciences Company Details

Table 101. Gilead Sciences Business Overview

Table 102. Gilead Sciences HIV Therapeutics Product

Table 103. Gilead Sciences Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)

Table 104. Gilead Sciences Recent Developments

Table 105. Johnson & Johnson Company Details

Table 106. Johnson & Johnson Business Overview

Table 107. Johnson & Johnson HIV Therapeutics Product

Table 108. Johnson & Johnson Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)

Table 109. Johnson & Johnson Recent Developments

Table 110. Cipla Limited Company Details

Table 111. Cipla Limited Business Overview

Table 112. Cipla Limited HIV Therapeutics Product

Table 113. Cipla Limited Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)

Table 114. Cipla Limited Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global HIV Therapeutics Market Share by Type: 2021 VS 2028

Figure 2. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Features

Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features

Figure 4. Entry and Fusion Inhibitors Features

Figure 5. Protease Inhibitors (PIs) Features

Figure 6. Integrase Inhibitors Features

Figure 7. Coreceptor Antagonists Features

Figure 8. Global HIV Therapeutics Market Share by Application: 2021 VS 2028

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Labs Case Studies

Figure 12. HIV Therapeutics Report Years Considered

Figure 13. Global HIV Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 14. Global HIV Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 15. Global HIV Therapeutics Market Share by Region: 2021 VS 2028

Figure 16. Global HIV Therapeutics Market Share by Players in 2021

Figure 17. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2021)

Figure 18. The Top 10 and 5 Players Market Share by HIV Therapeutics Revenue in 2021

Figure 19. North America HIV Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 20. North America HIV Therapeutics Market Size Market Share by Type (2017-2028)

Figure 21. North America HIV Therapeutics Market Size Market Share by Application (2017-2028)

Figure 22. North America HIV Therapeutics Market Size Share by Country (2017-2028)

Figure 23. United States HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. Canada HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 25. Europe HIV Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 26. Europe HIV Therapeutics Market Size Market Share by Type (2017-2028)

Figure 27. Europe HIV Therapeutics Market Size Market Share by Application (2017-2028)

Figure 28. Europe HIV Therapeutics Market Size Share by Country (2017-2028)

Figure 29. Germany HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. France HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. U.K. HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Italy HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Russia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. Nordic Countries HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 35. Asia-Pacific HIV Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 36. Asia Pacific HIV Therapeutics Market Size Market Share by Type (2017-2028)

Figure 37. Asia Pacific HIV Therapeutics Market Size Market Share by Application (2017-2028)

Figure 38. Asia Pacific HIV Therapeutics Market Size Share by Region (2017-2028)

Figure 39. China HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Japan HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. South Korea HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Southeast Asia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. India HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 44. Australia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 45. Latin America HIV Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 46. Latin America HIV Therapeutics Market Size Market Share by Type (2017-2028)

Figure 47. Latin America HIV Therapeutics Market Size Market Share by Application (2017-2028)

Figure 48. Latin America HIV Therapeutics Market Size Share by Country (2017-2028)

Figure 49. Mexico HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 50. Brazil HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 51. Middle East & Africa HIV Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 52. Middle East and Africa HIV Therapeutics Market Size Market Share by Type (2017-2028)

Figure 53. Middle East and Africa HIV Therapeutics Market Size Market Share by Application (2017-2028)

Figure 54. Middle East and Africa HIV Therapeutics Market Size Share by Country (2017-2028)

Figure 55. Turkey HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. Saudi Arabia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 57. UAE HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 58. Boehringer Ingelheim International GmbH Revenue Growth Rate in HIV Therapeutics Business (2017-2022)

Figure 59. Merck & Co. Revenue Growth Rate in HIV Therapeutics Business (2017-2022)

Figure 60. ViiV Healthcare Revenue Growth Rate in HIV Therapeutics Business (2017-2022)

Figure 61. AbbVie Revenue Growth Rate in HIV Therapeutics Business (2017-2022)

Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in HIV Therapeutics Business (2017-2022)

Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in HIV Therapeutics Business (2017-2022)

Figure 64. Bristol-Myers Squibb Revenue Growth Rate in HIV Therapeutics Business (2017-2022)

Figure 65. Gilead Sciences Revenue Growth Rate in HIV Therapeutics Business (2017-2022)

Figure 66. Johnson & Johnson Revenue Growth Rate in HIV Therapeutics Business (2017-2022)

Figure 67. Cipla Limited Revenue Growth Rate in HIV Therapeutics Business (2017-2022)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HIV Therapeutics Market Insights, Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-22W5974

Global HIV Therapeutics Market Insights, Forecast to 2028

FEATURED COMPANIES

HIV Therapeutics Market

By Type

By Application

By Company

By Region

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-3H6190

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-3P9630

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-24Y5897

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-35A3544

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions